工程化益生菌用于肿瘤靶向联合化学免疫治疗
Engineered probiotics for tumor-targeted combination chemoimmunotherapy.
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:Bacteria-Based Backpacks to Enhance Adoptive Macrophage Transfer against Solid Tumors.
Bacteria-Based Backpacks to Enhance Adoptive Macrophage Transfer against Solid Tumors.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
过继性细胞疗法已成为一种有前景的癌症治疗方法。然而,由于在免疫抑制性肿瘤微环境中细胞表型从抗肿瘤状态向促肿瘤状态动态转变,巨噬细胞的转移对实体瘤的疗效有限。在本研究中,报道了一种将细菌附着于巨噬细胞的策略(Mø@bac),通过利用细菌固有的免疫原性,赋予过继输注的巨噬细胞持久的刺激。这些附着的细菌被称为背包,被包裹在粘附性纳米涂层中,能够在体内持续控制细胞表型。此外,Mø@bac能够重新极化内源性肿瘤相关巨噬细胞,导致更强的免疫反应,从而在鼠4T1癌症模型中减少肿瘤进展,且无任何副作用。本研究利用细菌作为细胞背包,为细胞疗法的发展开辟了新途径。
Adoptive cell therapy has emerged as a promising approach for cancer treatment.
However, the transfer of macrophages exhibits limited efficacy against solid tumors due to the dynamic cellular phenotypic shift from antitumor to protumor states within the immunosuppressive tumor microenvironment.
In this study, a strategy of attaching bacteria to macrophages (Mø@bac) is reported that endows adoptively infused macrophages with durable stimulation by leveraging the intrinsic immunogenicity of bacteria. These attached bacteria, referred to as backpacks, are encapsulated with adhesive nanocoatings and can sustainably control the cellular phenotypes in vivo.
Moreover, Mø@bac can repolarize endogenous tumor-associated macrophages, leading to a more robust immune response and thus reducing the tumor progression in a murine 4T1 cancer model without any side effects.
This study utilizing bacteria as cellular backpacks opens a new avenue for the development of cell therapies.
MEMBER ACCOUNT
登录成功会直接打开下一页。